Jump to Navigation
Menu
Search
HOME
WHAT WE DO
MISSION STATEMENT
WHAT IS INNATE IMMUNITY
CORES
EDUCATION
IMMUNO-INFORMATICS
SIGNALING & HUMAN CELL TRANSGENICS
TRANSGENIC MOUSE
TRANSLATION
ADMINISTRATIVE
RESEARCH
AUTOIMMUNITY
CANCER
GENETICS
INFECTIOUS DISEASE
INFLAMATION
SIGNALING
VACCINES/THERAPEUTICS
EDUCATION
ABOUT THE EDUCATION CORE
PEOPLE
CENTER LEADERSHIP
MEMBERS
NEWS & EVENTS
EVENTS
Seminar
MEMBERSHIP
DONATE
About
Contact
You are here
Home
» How the Gale Lab “RIG”s innate immune responses against hepatitis B
How the Gale Lab “RIG”s innate immune responses against hepatitis B
How the Gale Lab “RIG”s innate immune responses against hepatitis B
From the Gale Lab, Pathogen Associated Malignancies Program, Cancer Consortium
Link to Fred Hutch article written by AE Spens
Recent News
How the Gale Lab “RIG”s innate immune responses against hepatitis B
CIIID response to COVID-19 and the SARS-CoV-2 pandemic
A new study led by Dr. Katharina Esser-Nobis reveals the intracellular molecular and biochemical interactions of RIG-I-like receptors (RLRs) during the process of innate immune activation directed by virus infection and double stranded RNA (dsRNA).